COLD-FX Extra Strength Capsules
Original price was: $19.00.$15.20Current price is: $15.20.
(In Stock)
COLD-FX Extra Strength Capsules
Being sick is never fun. And neither is missing out on life “!s amazing moments and important things because of cold or flu symptoms. Take COLD-FX EXTRA to help reduce the chances of catching cold and flu symptoms by boosting your immune system.* Don “!t forget to also take it when traveling.
Recommended Use:
COLD-FX EXTRA helps reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.* It helps reduce overall symptoms of sore throat, fever, cough, headache, runny nose, nasal congestion, sneezing, malaise, ear-aches and hoarseness.* It provides further reduction of cold and flu symptoms when taken with a flu shot.* COLD-FX EXTRA helps to increase production of certain types of cytokines that may signal and activate the immune system in high performing athletes.*
Recommended Dose:
Children 12 years of age and older: Take 1 capsule 2 times daily.
Adults:
Take 1 capsule 2 times daily, up to 6 capsules per day.
COLD-FX EXTRA may be taken for the duration of the Cold and Flu Season.
*Disclaimer
These statements have not been evaluated by Health Canada or the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medicinal Ingredients:
Each capsule contains 300 mg of the active ingredient CVT-E002, which is uniquely derived from the root of Panax quinquefolius (North American ginseng, 4:1, 1,200 mg).
Non-medicinal Ingredients:
Gelatin, natural capsule colour (chlorophyllin, titanium dioxide).
Contraindications:
Individuals with known allergies to ginseng should avoid use of COLD-FX. Do not use if pregnant or breastfeeding.
Individuals requiring anti-coagulant therapy such as warfarin should avoid the use of COLD-FX. Not recommended for individuals with impaired liver or renal function. Do not exceed the recommended daily dose. Consult a healthcare practitioner prior to use if you have diabetes.
Reviews
There are no reviews yet.